Although CTR is most commonly known for its role in bone and calcium homeostasis (reviewed in [12]), its expression has been demonstrated in a number of cancer cell lines and primary cancers including breast and prostate cancers, bone cancers, leukemia, multiple myeloma, thymic lymphoma and glioblastoma (reviewed in [12]). The gene discussed is CALCR; the disease is cancer.